10">sICAM-1 levels in the early stage of SZ were comparable to healthy controls.
15">sICAM-1 levels were elevated in the late stage of SZ compared to healthy controls.
sVCAM-1 levels were decreased in both stages of SZ compared to healthy controls.
sICAM-1 was related to the severity and type of symptoms in the early stage of SZ.
Lower sICAM-1 was related to favorable treatment application in both stages of SZ.